Correlation Between CONAGRA and Recursion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both CONAGRA and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CONAGRA and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CONAGRA BRANDS INC and Recursion Pharmaceuticals, you can compare the effects of market volatilities on CONAGRA and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CONAGRA with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CONAGRA and Recursion Pharmaceuticals.

Diversification Opportunities for CONAGRA and Recursion Pharmaceuticals

0.39

Correlation Coefficient

CONAGRA  Recursion Pharmaceuticals

Weak diversification

The 3 months correlation between CONAGRA and Recursion is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding CONAGRA BRANDS INC and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and CONAGRA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CONAGRA BRANDS INC are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of CONAGRA i.e., CONAGRA and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between CONAGRA and Recursion Pharmaceuticals

Assuming the 90 days trading horizon CONAGRA BRANDS INC is expected to generate 0.16 times more return on investment than Recursion Pharmaceuticals. However, CONAGRA BRANDS INC is 6.06 times less risky than Recursion Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Recursion Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  9,448  in CONAGRA BRANDS INC on December 26, 2024 and sell it today you would earn a total of  15.00  from holding CONAGRA BRANDS INC or generate 0.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

CONAGRA BRANDS INC  vs.  Recursion Pharmaceuticals

CONAGRA BRANDS INC

Risk-Adjusted Performance

Very Weak

Over the last 90 days CONAGRA BRANDS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CONAGRA is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Recursion Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Recursion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Recursion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with CONAGRA and Recursion Pharmaceuticals

The main advantage of trading using opposite CONAGRA and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CONAGRA position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.

The idea behind CONAGRA BRANDS INC and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.